These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36883180)

  • 41. [Effect of exogenous donors of nitric oxide and inhibitors of its enzymatic synthesis on experimental ischemic thrombosis in conjunctive veins of the rabbit eyes].
    Arkhipova MA; Mikoian VD; Vanin AF
    Biofizika; 2008; 53(2):315-25. PubMed ID: 18543774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The binuclear form of dinitrosyl iron complexes with thiol-containing ligands in animal tissues.
    Mikoyan VD; Burgova EN; Borodulin RR; Vanin AF
    Nitric Oxide; 2017 Jan; 62():1-10. PubMed ID: 27989818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of dinitrosyl iron complex with glutathione and its components on ischemic rat heart during reperfusion].
    Pisarenko OI; Shul'zhenko VS; Studneva IM; Pelogeĭkina IuA; Timoshin AA; Vanin AF
    Biofizika; 2009; 54(6):1081-7. PubMed ID: 20067190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential of NO donor furoxan as SARS-CoV-2 main protease (M
    Al-Sehemi AG; Pannipara M; Parulekar RS; Patil O; Choudhari PB; Bhatia MS; Zubaidha PK; Tamboli Y
    J Biomol Struct Dyn; 2021 Sep; 39(15):5804-5818. PubMed ID: 32643550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of dinitrosyl iron complex with glutathione as a nitric oxide donor on blood circulation in healthy animals].
    Remizova MI; Kochetygov NI; Gerbut KA; Vanin AF
    Biofizika; 2008; 53(5):867-73. PubMed ID: 18954017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro.
    Akaberi D; Krambrich J; Ling J; Luni C; Hedenstierna G; Järhult JD; Lennerstrand J; Lundkvist Å
    Redox Biol; 2020 Oct; 37():101734. PubMed ID: 33007504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of nitric oxide (NO) potential to mitigate COVID-19 severity.
    Srivastava S; Garg I; Hembrom AA; Kumar B
    Virusdisease; 2021 Sep; 32(3):589-594. PubMed ID: 34099981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome: dose response, prolonged inhalation, and weaning.
    Demirakça S; Dötsch J; Knothe C; Magsaam J; Reiter HL; Bauer J; Kuehl PG
    Crit Care Med; 1996 Nov; 24(11):1913-9. PubMed ID: 8917045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2).
    Lei C; Su B; Dong H; Bellavia A; Fenza RD; Fakhr BS; Gianni S; Grassi LG; Kacmarek R; Morais CCA; Pinciroli R; Vassena E; Berra L
    medRxiv; 2020 May; ():. PubMed ID: 32511534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The effect of thiol compounds and iron on formation of nitric oxide from nitroprusside and nitroglycerin].
    Kurbanov IS; Mordvintsev PI; Aliev DI; Vanin AF
    Vopr Med Khim; 1989; 35(6):87-91. PubMed ID: 2516930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Formation of paramagnetic nitrosyl complexes of non heme iron in animals with participation of nitric oxide from exogenous and endogenous sources].
    Mikoian VD; Serezhenkov VA; Brazhnikova NV; Kubrina LN; Khachatrian GN; Vanin AF
    Biofizika; 2004; 49(1):121-7. PubMed ID: 15029727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome Subsets: Rationale and Clinical Applications.
    Redaelli S; Pozzi M; Giani M; Magliocca A; Fumagalli R; Foti G; Berra L; Rezoagli E
    J Aerosol Med Pulm Drug Deliv; 2023 Jun; 36(3):112-126. PubMed ID: 37083488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
    Al Sulaiman K; Korayem GB; Altebainawi AF; Al Harbi S; Alissa A; Alharthi A; Kensara R; Alfahed A; Vishwakarma R; Al Haji H; Almohaimid N; Al Zumai O; Alrubayan F; Asiri A; Alkahtani N; Alolayan A; Alsohimi S; Melibari N; Almagthali A; Aljahdali S; Alenazi AA; Alsaeedi AS; Al Ghamdi G; Al Faris O; Alqahtani J; Al Qahtani J; Alshammari KA; Alshammari KI; Aljuhani O
    Crit Care; 2022 Oct; 26(1):304. PubMed ID: 36192801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Physico-chemistry of dinitrosyl iron complexes with thiol-containing ligands underlying their beneficial treatment of endometriosis].
    Vanin AF; Adamian LV; Burgova EN; Tkachev NA
    Biofizika; 2014; 59(4):766-75. PubMed ID: 25707245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lifestyle-mediated nitric oxide boost to prevent SARS-CoV-2 infection: A perspective.
    Kobayashi J
    Nitric Oxide; 2021 Oct; 115():55-61. PubMed ID: 34364972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-dose inhaled nitric oxide improves the oxygenation and ventilation of infants and children with acute, hypoxemic respiratory failure.
    Ream RS; Hauver JF; Lynch RE; Kountzman B; Gale GB; Mink RB
    Crit Care Med; 1999 May; 27(5):989-96. PubMed ID: 10362425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Critical role of nitric oxide in impeding COVID-19 transmission and prevention: a promising possibility.
    Rajendran R; Chathambath A; Al-Sehemi AG; Pannipara M; Unnikrishnan MK; Aleya L; Raghavan RP; Mathew B
    Environ Sci Pollut Res Int; 2022 Jun; 29(26):38657-38672. PubMed ID: 35258738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Redox conversions of dinitrosyl iron complexes with natural thiol-containing ligands.
    Borodulin RR; Kubrina LN; Serezhenkov VA; Burbaev DS; Mikoyan VD; Vanin AF
    Nitric Oxide; 2013 Nov; 35():35-41. PubMed ID: 23876349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms of nitric oxide protection against tert-butyl hydroperoxide-induced cytotoxicity in iNOS-transduced human erythroleukemia cells.
    Yalowich JC; Gorbunov NV; Kozlov AV; Allan W; Kagan VE
    Biochemistry; 1999 Aug; 38(33):10691-8. PubMed ID: 10451363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypothetical mechanism of light action on nitric oxide physiological effects.
    Vladimir T; Anatoly O; Larisa I; Vladimir P; Anna D; Аnna O
    Lasers Med Sci; 2021 Sep; 36(7):1389-1395. PubMed ID: 33104897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.